• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'b cell lymphoma'

T A ,A M ,C B ,Z M ,B D ,B D ,D L ,L K ,D A G ,R K ,P F ,E H ,J MorphologicandmolecularanalysisofRichtersyndromeinchroniclymphocyticleukaemiapatientstreatedwithibrutiniborvenetoclax HAEMATOLOGY

3 Richter transformation of chronic lymphocytic leukaemia (CLL) into mixed phenotype B-cell lymphoma with features of diffuse large B-cell lymphoma and classical Hodgkin lymphoma in

Protected

N/A

9
0
0
2022
Thalidomidkezelés relabált, diffúz nagy B-sejtes lymphomában idős betegekben

Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients..

Protected

N/A

7
0
0
2022
Up-Regulation of Lamin A/C Expression in Epstein-Barr Virus Immortalized B Cells and Burkitt Lymphoma Cell Lines of Activated B Cell Phenotype

We observed a high lamin A/C mRNA expression in EBV-immortalized B lymphoblastoid cell lines (LCLs) and in a subset of Burkitt lymphoma (BL) lines characterized by an activated B

Protected

N/A

8
0
0
2022
IN THE  DECOMPOSITION  OF  CALCIUM  CARBONATE

Records published by PAULIK, PAULIK and ERDEY [1] too are deficient in some data needed for calculation, therefore we tried to repeat the thermal measurements

Protected

N/A

12
0
0
2022
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children

Rituximab added to standard LMB chemotherapy markedly prolonged event-free survival and overall survival among children and adolescents with high-grade, high-risk, mature

Protected

N/A

13
0
0
2022
Roles of BCL-2 and MDR1 Expression in the Efficacy of Paclitaxel-based Lung Cancer Chemoradiation

Background: The associations between B-cell lymphoma 2 (BCL-2) and multi-drug resistance associated P- glycoprotein (MDR1) expressions and chemoradiotherapy outcome of patients

Protected

N/A

6
0
0
2022
Új és hagyományos irányok a gyermekkori akut lymphoblastos leukaemia biológiájában és ellátásában

ABL = Abelson murine leukemia viral oncogene homolog; ALL = akut lymphoblastos leukaemia; BCL2 = B-cell CLL/lymphoma 2; CD = cluster of differentiation; CDK = cyclin dependent

Protected

N/A

12
0
0
2022
MAGYAR-Path Study case from the three-dimensional speckle-trackingechocardiographic lymphoma patient with cardiac involvement:A Left ventricular rigid body rotation in a diffuse largeB-cell Cardiologia

Left ventricular rigid body rotation in a diffuse large B-cell lymphoma patient with cardiac involvement:.. A case from the three-dimensional speckle-tracking

Protected

N/A

5
0
0
2022
Folyadékbiopszia-vizsgálatok alkalmazási lehetőségei az onkohematológiában

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.. Scherer F, Kurtz DM, Newman AM,

Protected

N/A

13
0
0
2022
Infinite Elements in Acoustics

To fulfill the conditions of the Atkinson–Wilcox theorem, the enclosing sphere of the radiating object must be built by finite elements..

Protected

N/A

15
0
0
2023
Twenty-eight dogs (80%) had B-cell lympho- ma while seven dogs (20%) had T-cell lymphoma

Heteroduplex polymerase chain reaction for antigen receptor rearrange- ments (hPARR) was developed to monitor minimal residual disease (MRD) in canine B- and T-cell lymphomas

Protected

N/A

19
0
0
2022
Minekutánna tulajdonáv&aacute

mit nem ziirne zavarna az illyen Ember e’ mos­ tani Világban , fenekeitől bizony mindent fel forgatna , eröfeakoskodnék mindeneken, és a’ maga réfcét úgy kikivánná venni

Protected

N/A

52
0
0
2022
EPIDEMIOLOGY, CLINICAL AND CYTOLOGICAL  FEATURES OF LYMPHOMA IN BOXER DOGS

According to the Kiel classification the most common subtypes included the pleomorphic, mixed small and large lymphoma (Pleosl; n = 21; 40%), clear cell lymphoma (CC; n = 16;

Protected

N/A

17
0
0
2022
: : : : : : ’ sLymphomaPatients EvaluationofSignificanceofLymphocyteSubpopulationsandNon-specificSerologicMarkersinB-cellNon-Hodgkin

Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, Morishima Y (2008) Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma

Protected

N/A

6
0
0
2022
New Chalcone Derivative Inhibits ABCB1 in MultidrugResistant T-cell Lymphoma and Colon Adenocarcinoma Cells

The effect of the synthetic chalcone derivative 1C on cell growth was determined on mouse T-cell lymphoma cells and human colon adenocarcinoma cells expressing ABCB1 (MDR and

Protected

N/A

7
0
0
2022
Translational Research: Palatal-derived Ecto-mesenchymal Stem  Cells from Human Palate: A New Hope for Alveolar Bone

In order to understand the cellular origins of Neural Crest Stem Cells from Dental and Periodontal Tissues, transplanted tooth buds were used to show that the mesen-

Protected

N/A

7
0
0
2022
8. osztályos mozgássérült tanulók írásbeli véleményalkotásának vizsgálata

A 13 tanuló fogalmazásából tehát kiderül, hogy (1) képesek magukat írásban kifejezni, véleményt formálni és alkalmazni a vélemény kifejezőeszközeit úgy, hogy

Protected

N/A

13
0
0
2022
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin’s lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Interpretation Early consolidation with brentuximab vedotin after autologous stem-cell transplantation improved progression-free survival in patients with Hodgkin’s lymphoma with

Protected

N/A

10
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!